Neuroleptic malignant syndrome after haloperidol application;Malignes neuroleptisches syndrom nach haloperidolapplikation

Anaesthesist

Volumn 50, Issue 5, 2001, Pages 329-332

  Gerbershagen, M U ^a   Ito, W D ^a   Wappler, F ^a   Fiege, M ^a   Schulte am Esch, J ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Creatine phosphokinase; Haloperidol; Hyperthermia; Muscle rigidity; Neuroleptic malignant syndrome

Indexed keywords

CATECHOLAMINE; CREATINE KINASE; DANTROLENE; DIAZEPAM; HALOPERIDOL; LIVER ENZYME; MIRTAZAPINE;

ADRENERGIC SYSTEM; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CASE REPORT; CONSCIOUSNESS DISORDER; CREATINE KINASE BLOOD LEVEL; DEPRESSION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; HUMAN; HYPERACTIVITY; HYPERTHERMIA; LEUKOCYTOSIS; LIVER DYSFUNCTION; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PATHOGENESIS; PNEUMONIA; PSYCHOSIS; REHYDRATION; SKELETAL MUSCLE;

AGED; ANTIPSYCHOTIC AGENTS; CATECHOLAMINES; DANTROLENE; DEPRESSIVE DISORDER; HALOPERIDOL; HUMANS; INTENSIVE CARE; LIVER FUNCTION TESTS; MALE; MUSCLE RELAXANTS, CENTRAL; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0035010151     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010170017     Document Type: Article

References (19)

1. Epidemiology of neuroleptic malignant syndrome
2. The association between the neuroleptic malignant syndrome and malignant hyperthermia
3. The neuroleptic malignant syndrome
4. Neuroleptic malignant syndrome
5. Traitement du syndrome malin des neuroleptiques par le dantrolene
6. Un neuroleptique majeur nonphenothiazine et non-reserpin, l'haloperidol, dans le traitment des psychoses
7. Neuroleptic malignant syndrome and catatonia: One entity or two?
8. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome
9. Current concepts: Neuroleptic malignant syndrome
10. Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique
11. Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade?
12. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death
13. "Katatones Dilemma": Therapie mit lorazepam und clozapin
14. Treatment of neuroleptic malignant syndrome with electroconvulsive therapy
15. Neuroleptic malignant syndrome
16. Neuroleptic malignant syndrome: Results of a prospective study
17. Neuroleptic malignant syndrome: Review of response to therapy
18. Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man